NCT03670615

Brief Summary

Mild cognitive impairment and Alzheimer's disease are conditions that involve memory difficulties. Transcranial direct current stimulation is a type of brain stimulation. It may help improve these memory difficulties. However, it works better on active brain areas. This study looks at if combining exercise and applying current to important parts of the brain can help improve memory in people with Mild Cognitive Impairment or Alzheimer's disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 13, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

November 28, 2018

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2025

Completed
Last Updated

March 30, 2026

Status Verified

May 1, 2025

Enrollment Period

6.7 years

First QC Date

August 22, 2018

Last Update Submit

March 25, 2026

Conditions

Keywords

Alzheimer diseasecognitiontranscranial direct current stimulationexercisemild cognitive impairment

Outcome Measures

Primary Outcomes (1)

  • Alzheimer's Disease Assessment Scale Cog (ADAS-Cog) - Word Recognition Task errors at study endpoint (T3)

    Assess recognition memory. Words incorrectly recognized will be tallied. Word Recognition scores range from 0 to 12. Higher scores represent a worse outcome.

    Study endpoint (two-weeks post baseline)

Secondary Outcomes (4)

  • n-back reaction time at study endpoint (T3)

    Study endpoint (two-weeks post baseline)

  • Alzheimer's Disease Assessment Scale-Cog (ADAS-Cog) - Word Recall Task at study endpoint (T3)

    Study endpoint (two-weeks post baseline)

  • The Montreal Cognitive Assessment (MoCA) Total at study endpoint (T3)

    Study endpoint (two-weeks post baseline)

  • The Neuropsychiatric Inventory (NPI) at study endpoint (T3)

    Study endpoint (two-weeks post baseline)

Other Outcomes (1)

  • Concentration of blood biomarkers of brain plasticity at study endpoint (T3)

    Study endpoint (two-weeks post baseline)

Study Arms (3)

Exercise and tDCS

EXPERIMENTAL

Patients randomized to this group will attend Toronto Rehabilitation Institute - University Health Network (TRI-UHN) for an individualized exercise program and active tDCS intervention.

Other: tDCSOther: Exercise

Exercise Education and tDCS

OTHER

Patients randomized to this group will undergo treatment as usual, receiving routine advice about physical activity and active tDCS intervention.

Other: tDCSOther: Exercise Education

Exercise and Sham tDCS

OTHER

Patients randomized to this group will attend TRI-UHN for an individualized exercise program and sham tDCS intervention.

Other: ExerciseOther: Sham tDCS

Interventions

tDCSOTHER

All study participants randomized to tDCS will receive active tDCS.

Exercise Education and tDCSExercise and tDCS

Participants will exercise at TRI according to an individualized exercise prescription.

Exercise and Sham tDCSExercise and tDCS

Exercise education/ treatment as usual will include routine advice about physical activity for older adults.

Also known as: Treatment as usual
Exercise Education and tDCS

The same procedure for tDCS will be used for the sham condition, except without active current.

Exercise and Sham tDCS

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males or females ≥50 years of age
  • DSM-5 criteria for major or mild neurocognitive disorder due to AD or mixed AD/vascular disease
  • Mild severity of impairment (standardized Mini-Mental State Examination (MMSE) score ≥19)
  • Read and communicate in English

You may not qualify if:

  • Change in cognitive enhancing medications (ChEIs and/or memantine) less than 3 months prior to study screen
  • Change in anticonvulsants or psychotropic medications less than 1 month prior to study screen
  • Currently taking benzodiazepines
  • Presence of metal implants that would preclude safe use of tDCS (e.g. pace-maker)
  • Significant neurological condition (e.g. epilepsy, Parkinson's disease, multiple sclerosis)
  • Current psychiatric disorders (e.g. schizophrenia, bipolar disorder, depression, psychosis) or current substance use disorder
  • Medical contraindications to increasing activity level according to the Canadian Society of Exercise Physiology Questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnybrook Health Sciences Centre

Toronto, Ontario, M3H0A7, Canada

Location

Related Publications (1)

  • Liu CS, Herrmann N, Song BX, Ba J, Gallagher D, Oh PI, Marzolini S, Rajji TK, Charles J, Papneja P, Rapoport MJ, Andreazza AC, Vieira D, Kiss A, Lanctot KL. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease. BMC Geriatr. 2021 Dec 4;21(1):677. doi: 10.1186/s12877-021-02636-6.

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseMotor Activity

Interventions

Transcranial Direct Current StimulationExerciseTherapeutics

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesBehavior

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The research personnel that will be administering the cognitive assessments will be blinded to treatment allocation. The patients will be blinded to stimulation type.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized, blinded, repeated-session, parallel-design study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2018

First Posted

September 13, 2018

Study Start

November 28, 2018

Primary Completion

August 1, 2025

Study Completion

August 6, 2025

Last Updated

March 30, 2026

Record last verified: 2025-05

Locations